20 articles
Bacterial metabolite from flavonoids protects against graft-versus-host disease while preserving anti-cancer effects in stem cell transplants.
6-methoxykaempferol from sweet cherries restored immune function by 43% and improved beneficial gut bacteria in immunocompromised mice.
Engineered cerium-peptide microspheres show 76% reduction in IBD symptoms and 66% decrease in fibrosis markers in mouse studies.
Study shows probiotic bacteria shields heart muscle from toxic effects of cancer chemotherapy through metabolite pathway.
A common oat fiber supercharges anti-PD-1 checkpoint therapy by expanding a key gut microbe that produces immune-activating metabolites.
Small pilot study tests whether resistant starch from potatoes can safely modify gut bacteria in cancer patients receiving dual checkpoint inhibitors.
New research shows how a specific gut bacteria enhances anti-PD-1 therapy effectiveness in hard-to-treat colorectal cancers.
A stem cell intestine model screened 3,500 compounds and flagged glycyrrhizin from black licorice as a top anti-inflammatory candidate for IBD.
New research reveals how skin microbes trigger severe immune reactions to cancer treatments, offering hope for prevention strategies.
Fecal transplants from cancer survivors significantly improved treatment outcomes for metastatic kidney cancer patients.
Real-world Australian study shows promising results for teduglutide in reducing dependency on IV nutrition in short bowel syndrome patients.
New research reveals how specific gut bacteria produce compounds that interfere with cancer treatment effectiveness.
Study of 270 patients reveals specific gut microbes linked to better survival and fewer severe side effects from immunotherapy.
New research shows electroacupuncture improves motor function and protects brain cells in Parkinson's disease through protein regulation.
Scientists discover how intestinal cells starve harmful Candida fungi of essential zinc to prevent colonization and overgrowth.
Groundbreaking clinical trial reveals how switching to traditional African foods dramatically improves immune function and reduces inflammation.
Clinical trial tests safety of combined prebiotic-probiotic supplement in 32 healthy participants over 5 months.
New research reveals how certain gut bacteria weaken immune responses against tumors by consuming asparagine, potentially undermining cancer treatments.
A comprehensive review reveals how SCFAs, bile acids, and tryptophan metabolites reshape the tumor immune microenvironment in GI cancers.
A landmark review reveals how diet, gut bacteria, and their metabolites determine the success of immune checkpoint blockade cancer therapy.
